Attorney General Kris Mayes wants the U.S. Food and Drug Administration to remove restrictions on one of two drugs used in non-surgical abortions.

The drug, Dawnzera, is approved to prevent symptoms of a rare genetic disease called hereditary angioedema (HAE) in adults and pediatric patients over 12 years old. The condition causes frequent ...

Ionis Pharmaceuticals won FDA approval for a drug that prevents painful swelling attacks triggered by a rare genetic condition, hereditary angioedema.

In 2024, Hurricane Helene triggered a nationwide shortage of the country's intravenous (IV) fluids after damaging a facility in North Carolina. A similar IV fluid shortage was caused when Hurricane ...

A team of researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai has successfully treated a rare and aggressive T-cell lymphoma that developed after CAR T-cell ...

Ionis on Thursday said the FDA green light covers Dawnzera for prophylaxis to prevent attacks of hereditary angioedema in patients 12 years of age and older and makes the drug is the first and only ...

Dawnzera is the third medicine cleared by U.S. regulators this year for the rare genetic condition, and the second wholly owned medicine Ionis has brought to market.

The recalled frozen shrimp were sent to 13 different states and were shipped into the country through four different ports.

The FDA approved the Dako Omnis panel to identify patients with colorectal cancer with mismatch repair deficiency.

The U.S. Food and Drug Administration has approved Papzimeos (zopapogene imadenovec-drba) for the treatment of adults with ...

The sNDA for acquired hyothalamic obesity is supported by data from the randomized, double-blind, placebo-controlled phase 3 TRANSCEND trial.

FluMist is now approved by the U.S. Food and Drug Administration for use at home, and it can be ordered online. It is the ...